The phytoestrogen genistein affects inflammatory-related genes expression depending on the ERα/ERβ ratio in breast cancer cells

References

• Adlercreutz H. 2002. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol. 83(1–5):113–118.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Reddy GV, Reddanna P. 2009. Eicosanoids in inflammation and cancer: the role of COX-2. Expert Rev Clin Immunol. 5(2):145–165.
   PubMed Web of Science ®Google Scholar
• Band AM, Laiho M. 2011. Crosstalk of TGF-β and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia. 16(2):109–115.
   PubMed Web of Science ®Google Scholar
• Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau M-M, Netter P, Terlain B, Jouzeau J-Y. 2005. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2. Arthritis Res Ther. 7(6):R1325.
   PubMed Web of Science ®Google Scholar
• Bièche I, Parfait B, Laurendeau I, Girault I, Vidaud M, Lidereau R. 2001. Quantification of estrogen receptor α and β expression in sporadic breast cancer. Oncogene. 20(56):8109–8115.
   PubMed Web of Science ®Google Scholar
• Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, Aakre M, Shyr Y, Moses HL. 2009. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest. 119(6):1571–1582.
   PubMed Web of Science ®Google Scholar
• Bouker KB, Hilakivi-Clarke L. 2000. Genistein: does it prevent or promote breast cancer? Environ Health Perspect. 108(8):701–708.
   PubMed Web of Science ®Google Scholar
• Carter AB, Misyak SA, Hontecillas R, Bassaganya-Riera J. 2009. Dietary modulation of inflammation-induced colorectal cancer through PPARγ. PPAR Res. 2009:1–9.
   Google Scholar
• Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature. 420(6917):860–867.
   PubMed Web of Science ®Google Scholar
• Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, Henley SJ, Anderson RN, Firth AU, Ma J, et al. 2018. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer. 124(13):2785–2800.
   PubMed Web of Science ®Google Scholar
• Dieterich M, Stubert J, Reimer T, Erickson N, Berling A. 2014. Influence of lifestyle factors on breast cancer risk. Breast Care. 9(6):407–414.
   PubMed Web of Science ®Google Scholar
• Fernández M, Reina-Pérez I, Astorga J, Rodríguez-Carrillo A, Plaza-Díaz J, Fontana L. 2018. Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health. 15(8):1747.
   Web of Science ®Google Scholar
• Gillum MP, Kotas ME, Erion DM, Kursawe R, Chatterjee P, Nead KT, Muise ES, Hsiao JJ, Frederick DW, Yonemitsu S, et al. 2011. SirT1 regulates adipose tissue inflammation. Diabetes. 60(12):3235–3245.
   PubMed Web of Science ®Google Scholar
• Hartman J, Ström A, Gustafsson JÅ. 2009. Estrogen receptor beta in breast cancer-diagnostic and therapeutic implications. Steroids. 74(8):635–641.
   PubMed Web of Science ®Google Scholar
• Helguero LA, Faulds MH, Gustafsson J-Å, Haldosén L-A. 2005. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene. 24(44):6605–6616.
   PubMed Web of Science ®Google Scholar
• Honma S, Shimodaira K, Shimizu Y, Tsuchiya N, Saito H, Yanaihara T, Okai T. 2002. The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J. 49(3):371–377.
   PubMed Web of Science ®Google Scholar
• James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Mesrine S, Engel P, et al. 2011. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study. Cancer Prev Res. 4(10):1626–1635.
   PubMed Web of Science ®Google Scholar
• Jana D, Sarkar DK, Ganguly S, Saha S, Sa G, Manna AK, Banerjee A, Mandal S. 2014. Role of cyclooxygenase 2 (COX-2) in prognosis of breast cancer. Indian J Surg Oncol. 5(1):59–65.
   PubMedGoogle Scholar
• Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. 2013. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 25(10):1939–1948.
   PubMed Web of Science ®Google Scholar
• Key TJ, Verkasalo PK, Banks E. 2001. Epidemiology of breast cancer. Lancet Oncol. 2(3):133–140.
   PubMed Web of Science ®Google Scholar
• Koroma BM, de Juan E. 1997. Inhibition of protein tyrosine phosphorylation in endothelial cells: relationship to antiproliferative action of genistein. Biochem Soc Trans. 25(1):35–40.
   PubMed Web of Science ®Google Scholar
• Kostelac D, Rechkemmer G, Briviba K. 2003. Phytoestrogens modulate binding response of estrogen receptors α and β to the estrogen response element. J Agric Food Chem. 51(26):7632–7635.
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138(3):863–870.
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139(10):4252–4263.
   PubMed Web of Science ®Google Scholar
• Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. 1987. Functional domains of the human estrogen receptor. Cell. 51(6):941–951.
   PubMed Web of Science ®Google Scholar
• Kurtzman SH, Anderson KH, Wang YP, Miller LJ, Renna M, Stankus M, Lindquist RR, Barrows G, Kreutzer DL. 1999. Cytokines in human breast cancer: IL-1alpha and IL-1beta expression. Oncol Rep. 6(1):65–70.
   PubMed Web of Science ®Google Scholar
• Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J. 2008. Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol In Vitro. 22(7):1749–1753.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature. 454(7203):436–444.
   PubMed Web of Science ®Google Scholar
• Martinez-Pastor B, Mostoslavsky R. 2012. Sirtuins, metabolism, and cancer. Front Pharmacol. 3:22.
   PubMed Web of Science ®Google Scholar
• Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A. 1993. Genistein arrests cell cycle progression at G2-M. Cancer Res. 53(6):1328–1331.
   PubMed Web of Science ®Google Scholar
• Morton MS, Arisaka O, Miyake N, Morgan LD, Evans B. 2002. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr. 132(10):3168–3171.
   PubMed Web of Science ®Google Scholar
• Mukund V, Mukund D, Sharma V, Mannarapu M, Alam A. 2017. Genistein: Its role in metabolic diseases and cancer. Crit Rev Oncol Hematol. 119:13–22.
   PubMed Web of Science ®Google Scholar
• Nadal-Serrano M, Pons DG, Sastre-Serra J, Blanquer-Rossello MM, Roca P, Oliver J. 2013. Genistein modulates oxidative stress in breast cancer cell lines according to ERalpha/ERbeta ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes. Int J Biochem Cell Biol. 45(9):2045–2051.
   PubMed Web of Science ®Google Scholar
• Nadal-Serrano M, Sastre-Serra J, Pons DG, Miró AM, Oliver J, Roca P. 2012. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17Beta-estradiol. J Cell Biochem. 113(10):3178–3182.
   PubMed Web of Science ®Google Scholar
• Perrier S, Caldefie-Chézet F, Vasson MP. 2009. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines. FEBS Lett. 583(2):259–265.
   PubMed Web of Science ®Google Scholar
• Poligone B, Baldwin AS. 2001. Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins. J Biol Chem. 276(42):38658–38664.
   PubMed Web of Science ®Google Scholar
• Pons DG, Nadal-Serrano M, Blanquer-Rossello MM, Sastre-Serra J, Oliver J, Roca P. 2014. Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. J Cell Biochem. 115(5):949–958.
   PubMed Web of Science ®Google Scholar
• Pons DG, Torrens-Mas M, Nadal-Serrano M, Sastre-Serra J, Roca P, Oliver J. 2015. The presence of estrogen receptor β modulates the response of breast cancer cells to therapeutic agents. Int J Biochem Cell Biol. 66:85–94.
   PubMed Web of Science ®Google Scholar
• Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. 2010. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 49(11):1603–1616.
   PubMed Web of Science ®Google Scholar
• Richards WL, Song MK, Krutzsch H, Evarts RP, Marsden E, Thorgeirsson SS. 1985. Measurement of cell proliferation in microculture using Hoechst 33342 for the rapid semiautomated microfluorimetric determination of chromatin DNA. Exp Cell Res. 159(1):235–246.
   PubMed Web of Science ®Google Scholar
• Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA. 1997. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res. 26(1):63–70.
   PubMed Web of Science ®Google Scholar
• Sastre-Serra J, Nadal-Serrano M, Pons DG, Roca P, Oliver J. 2012a. Mitochondrial dynamics is affected by 17??-estradiol in the MCF-7 breast cancer cell line. Effects on fusion and fission related genes. Int J Biochem Cell B. 44(11):1901–1905.
   PubMed Web of Science ®Google Scholar
• Sastre-Serra J, Nadal-Serrano M, Pons DG, Valle A, Garau I, García-Bonafé M, Oliver J, Roca P. 2013. The oxidative stress in breast tumors of postmenopausal women is ERα/ERβ ratio dependent. Free Radical Bio Med. 61:11–17.
   PubMed Web of Science ®Google Scholar
• Sastre-Serra J, Nadal-Serrano M, Pons DG, Valle A, Oliver J, Roca P. 2012b. The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio. Cell Physiol Biochem. 29(1–2):261–268.
   PubMed Web of Science ®Google Scholar
• Spagnuolu C, Russo GL, Orhan Llkay E, Habtemariam S, Daglia M, Sureda A, Nabavi SF, Devi KP, Loizzo MR, Tundis R, et al. 2015. Genistein and cancer: current status, challenges, and future directions. Adv Nutr. 6:408–419.
   PubMed Web of Science ®Google Scholar
• Stope MB, Popp SL, Knabbe C, Buck MB. 2010. Estrogen receptor α attenuates transforming growth factor-β signaling in breast cancer cells independent from agonistic and antagonistic ligands. Breast Cancer Res Treat. 120(2):357–367.
   PubMed Web of Science ®Google Scholar
• Tak PP, Firestein GS, Tak PP, Firestein GS. 2001. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 107(1):7–11.
   PubMed Web of Science ®Google Scholar
• Vachharajani VT, Liu T, Wang X, Hoth JJ, Yoza BK, McCall CE. 2016. Sirtuins link inflammation and metabolism. J Immunol Res. 2016:8167273.
   PubMed Web of Science ®Google Scholar
• Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A. 2003. Genistein as an anti-inflammatory agent. Inflamm Res. 52(8):341–346.
   PubMed Web of Science ®Google Scholar
• Barros RPA, Machado UF, Warner M, Gustafsson JA. 2006. Proc Natl Acad Sci USA. 103(5):1605–1608.
   PubMed Web of Science ®Google Scholar
• Xu B, Chen H, Xu W, Zhang W, Buckley S, Zheng SG, Warburton D, Kolb M, Gauldie J, Shi W. 2012. Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice. Am J Physiol Lung Cell Mol Physiol. 303(2):L89–L96.
   PubMed Web of Science ®Google Scholar
• Yang D, Elner SG, Bian ZM, Till GO, Petty HR, Elner VM. 2007. Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp Eye Res. 85(4):462–472.
   PubMed Web of Science ®Google Scholar
• Zarzynska JM. 2014. Two faces of TGF-beta1 in breast cancer. Mediat Inflamm. 2014:141747.
   PubMed Web of Science ®Google Scholar